US$310 – $2,200
The mRNA-Fect can be ordered in several configurations depending on application needs:
For more information about the mRNA-Fect reagent, please see the product brochure
| mRNA Transfection | Transfection reagents for mRNA delivery in both in vitro and in vivo models. | ||||
| mRNA-Fect Kit is recommended for better efficacy in hard-to-transfect cell types | |||||
| mRNA-Fect Kit contains 1 vial of mRNA-Fect and 1 vial of Trans-Booster | |||||
 | |||||
| SKU | Pack Size (mL) | Concentration (mg/mL) | Price (USD) | ||
| mRNA-Fect | 80-10 | 0.75 | 1.00 | 310 | |
| 80-20 | 1.50 | 1.00 | 558 | ||
| mRNA-Fect In Vivo | 80-30 | 1.00 | 5.00 | 1575 | |
| mRNA-Fect Kit | 80-40 | 0.75 | 1.00 | 430 | |
| 80-50 | 1.50 | 1.00 | 774 | ||
| mRNA-Fect In Vivo Kit | 80-60 | 1.0 / 1.0 | 5.0 / 2.0 | 2200 | |
| Benefits | 1. High transfection efficiency in the presence of serum. 2. Effective delivery of mRNA molecules via a simple protocol that is ideal for scale-up and automation. 3. Minimal toxicity compared to other commercial reagents, minimally affecting highly sensitive human cells. 4. Non-integrating transfection reagent eliminates adverse effects due to host genome integration. 5. Possibility of using the same transfection reagent in animal models, leading to harmonized studies. 6. Cost-effective reagent minimizing additional costs in nucleic acid screens. | ||||
310
mRNA-Fect is a highly effective transient transfection reagent optimized for mRNA delivery to both attachment-depended and suspension-growing cells. mRNA-Fect is a synthetic amphiphilic polymer that is tailored for mRNA delivery after extensive testing of amphiphilic polymer libraries. It is capable of undergoing multivalent interactions with polynucleotides and encapsulating co-incubated mRNA into ~100 nm particles with a net positive charge. The complexation between the mRNA and mRNA-Fect occurs in aqueous buffers, obviating the need for organic solvents during preparation. mRNA-Fect is a non-integrating carrier, so that the genetic make-up of host cells is not altered after treatment with this reagent. mRNA-Fect has been tested and found effective for plasmid DNA and siRNA delivery as well as in certain cell types. As with all transfection reagents, formulations of mRNA-Fect with polynucleotides may need to be optimized for specific cell types and transfection conditions.
| Property | mRNA-Fect |
| Technology | Polymeric |
| Nucleic Acid | mRNA |
| Cell Types | Suspension, Attachment |
| Transfection Type | Transient |
| High Throughput | Compatible |
| Serum | Compatible |
| Buffer | Aqueous |
| Storage Temperature | -20 ºC |
| Shelf Life at -20 ºC | ~1 year |
| Plate Size | Number of Transfections |
|---|---|
| 6-well (1200 µL/well) | 40 – 330 |
| 24-well (800 µL/well) | 60 – 500 |
| 48-well (400 µL/well) | 125 – 1000 |
| 96-well (200 µL/well) | 250 – 2000 |
RJH manufactures a variety of transfection agents for your R&D needs. Download our catalogue for a list of our products.
